deoxynivalenol has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul, NS; Chuturgoon, AA; Ghazi, T; Nagiah, S; Ndlovu, S | 1 |
| Didier, A; Dietrich, R; Lippke, H; Märtlbauer, E; Nielsen, C | 1 |
2 other study(ies) available for deoxynivalenol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Deoxynivalenol downregulates NRF2-induced cytoprotective response in human hepatocellular carcinoma (HepG2) cells.
Topics: Antioxidants; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Trichothecenes | 2021 |
Potential of deoxynivalenol to induce transcription factors in human hepatoma cells.
Topics: Activating Transcription Factor 3; Carcinoma, Hepatocellular; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Profiling; Humans; Liver Neoplasms; MAP Kinase Signaling System; Mycotoxins; Transcription Factors; Trichothecenes | 2009 |